Adverse effects of endocrine disruptors on the foetal testis development: Focus on the phthalates

Folia Histochemica et Cytobiologica

Volumn 47, Issue 5, 2009, Pages

  Habert, René ^a,b   Muczynski, Vincent ^a,b   Lehraiki, Abdelali ^a,b   Lambrot, Romain ^a,b   Lécureuil, Charlotte ^a,b   Levacher, Christine ^a,b   Coffigny, Hervé ^a,b   Pairault, Catherine ^a,b   Moison, Delphine ^a,b   Frydman, René ^c   Rouiller Fabre, Virginie ^a,b  

^a Universite Paris Sud   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Development; Endocrine disruptors; Environment; Foetus; Germ cells; Health; Phthalates; Reproduction; Testis; Testosterone

Indexed keywords

ENDOCRINE DISRUPTOR; LUTEINIZING HORMONE; PHTHALIC ACID; PHTHALIC ACID 2 ETHYLHEXYL MONOESTER; PHTHALIC ACID BIS(2 ETHYLHEXYL) ESTER; TESTOSTERONE;

APOPTOSIS; BODY FLUID; CELL PROLIFERATION; CRYPTORCHISM; DEL CASTILLO SYNDROME; ENVIRONMENTAL EXPOSURE; FETUS DEVELOPMENT; GERM CELL; GONADAL DYSGENESIS; HUMAN; HYPOSPADIAS; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; ORGAN CULTURE TECHNIQUE; PERINATAL DEVELOPMENT; REPRODUCTIVE TOXICITY; REVIEW; SPERMATOZOON COUNT; TESTIS CANCER; TESTIS DEVELOPMENT; ANIMAL; MALE; METABOLISM; TESTIS; TESTIS TUMOR;

RATTUS; RODENTIA;

ANIMALS; ENDOCRINE DISRUPTORS; HUMANS; MALE; TESTICULAR NEOPLASMS; TESTIS; TESTOSTERONE;

EID: 75949112154     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0056-5     Document Type: Review

References (79)

1. Sharpe RM, Irvine DS. How strong is the evidence of a link between environmental chemicals and adverse effects on human reproductive health? BMJ. 2004;328:447-451.
2. Delbes G, Levacher C, Habert R. Estrogen effects on fetal and neonatal testicular development. Reproduction. 2006;132: 527-538.
3. Leridon H, Slama R. The impact of a decline in fecundity and of pregnancy postponement on final number of children and demand for assisted reproduction technology. Hum Reprod. 2008;23:1312-1319
4. Vos JG, Dybing E, Greim HA, Ladefoged O, Lambre C, Tarazona JV, Brandt I, Vethaak AD. Health effects of endocrinedisrupting chemicals on wildlife, with special reference to the European situation. Crit Rev Toxicol. 2000;30:71-133.
5. Guillette LJ Jr, Gross TS, Masson GR, Matter JM, Percival HF & Woodward AR. Developmental abnormalities of the gonad and abnormal sex hormone concentrations in juvenile alligators from contaminated and control lakes in Florida. Environ Health Perspect. 1994;102:680-688.
6. Guillette LJ Jr, Guillette EA. Environmental contaminants and reproductive abnormalities in wildlife: implications for public health? Toxicol Industr Health. 1996;12:537-550.
7. Oskam IC, Ropstad E, Dahl E, Lie E, Derocher AE, Wiig O, Larsen S, Wiger R & Skaare JU. Organochlorines affect the major androgenic hormone, testosterone, in male polar bears (Ursus maritimus) at Svalbard. J Toxicol Environ Health. 2003;Part A 66:2119-2139.
8. Edwards TM, Moore BC, Guillette LJ Jr. Reproductive dysgenesis in wildlife: a comparative view. Int J Androl. 2006; 29:109-121.
9. Mackenzie CA, Lockridge A, Keith M. Declining sex ratio in a first nation community. Environ Health Perspect. 2005;113:1295-1298.
10. Toppari J. Environmental endocrine disrupters and disorders of sexual differentiation. Semin Reprod Med. 2002;20:305-312.
11. Auger J, Kunstmann JM, Czyglik F, Jouannet P. Decline in semen quality among fertile men in Paris during the past 20 years. NEJM. 1995;332:281-285.
12. Virtanen HE, Rajpert-De Meyts E, Main KM, Skakkebaek NE, Toppari J. Testicular dysgenesis syndrome and the development and occurrence of male reproductive disorders. Toxicol Applied Pharmacol. 2005;207 501-505.
13. Kaleva M, Virtanen HE, Haavisto AM, Main KM, Reunanen M, Skakkebaek NE & Toppari J. Circannual rhythm in the incidence of cryptorchidism in Finland. Int J Androl. 2005;28 53-57.
14. Davenport M. Risk of testicular cancer in boys with cryptorchidism. Study was based on small number of cancers. BMJ. 1997;315:1462-1463.
15. Moller H & Skakkebaek NE. Risk of testicular cancer in subfertile men: case-control study. BMJ. 1999;318:559-562.
16. Skakkebaek NE, Rajpert-De Meyts E, Main KM. Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Human Reprod. 2001;16: 972-978. (Pubitemid 32451837)
17. Skakkebaek NE, Jorgensen N. Testicular dysgenesis and fertility. Andrologia. 2005;37:217-218.
18. Olaso R, Habert R. Genetic and cellular analysis of male germ cell development. J Androl. 2000;21:497-511.
19. Kubota Y, Temelcos C, Bathgate RA, Smith KJ, Scott D, Zhao C, Hutson JM. The role of insulin 3, testosterone, Mullerian inhibiting substance and relaxin in rat gubernacular growth. Mol Human Reprod. 2002;8:900-905.
20. Habert R, Lejeune H & Saez JM. Origin, differentiation and regulation of fetal and adult Leydig cells. Mol Cell Endocrinol. 2001;179:47-74.
21. Skakkebaek NE, Bancroft J, Davidson DW, Warner P. Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study. Clin Endocrinol. 1981;14:49-61.
22. Meyts E, Jorgensen N, Brondum-Nielsen K, Muller J, Skakkebaek NE. Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS. 1998;106:198-204 (Discussion 204-196).
23. Moreno SG, Dutrillaux B, Coffigny H. Status of p53, p21, mdm2, pRb proteins, and DNA methylation in gonocytes of control and gamma-irradiated rats during testicular development. Biol Reprod 2001;64:1422-1431.
24. Forand A, Messiaen S, Habert R, & Bernardino-Sgherri J. Exposure of the mouse perinatal testis to radiation leads to hypospermia at sexual maturity Reproduction. (in press).
25. Orth JM, Gunsalus GL, Lamperti A. Evidence from sertoli celldepleted rats indicates that spermatid number in adults depends on numbers of sertoli cells produced during perinatal development. Endocrinology. 1988;122:787-794.
26. Sharpe RM. Pathways of endocrine disruption during male sexual differentiation and masculinization. Best Pract Res Clin Endocrinol Metab. 2006;20:91-110.
27. Sharpe RM, Skakkebaek NE. Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril. 2008;89(2 Suppl):33-38.
28. Wohlfahrt-Veje C, Main KM, Skakkebæ k NE. Testicular Dysgenesis Syndrome; Fetal origin of adult reproductive problems. Clin Endocrinol (Oxf). 2009 Feb 16. [Epub ahead of print]
29. Becker K, Seiwert M, Angerer J, Heger W, Koch HM, Nagorka R, Rosskamp E, Schlüter C, Seifert B, Ullrich D. DEHP metabolites in urine of children and DEHP in house dust. Int J Hyg Environ Health. 2004;207:409-417.
30. Koch HM, Preuss R, Angerer J. Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure-- an update and latest results. Int J Androl. 2006;29:155-165.
31. Wormuth M, Scheringer M, Vollenweider M, Hungerbuhler K. What are the sources of exposure to eight frequently used phthalic acid esters in Europeans? Risk Anal. 2006;26:803-824.
32. Latini G. Monitoring phthalate exposure in humans. Clin Chim Acta. 2005;361:20-29.
33. Koch HM, Bolt HM, Preuss R, Angerer J. New metabolites of di(2- ethylhexyl)phthalate (DEHP) in human urine and serum after single oral doses of deuteriumlabeled DEHP. Arch Toxicol. 2005;79:367-376.
34. Koch HM, Drexler H, Angerer J. An estimation of the daily intake of di(2- ethylhexyl)phthalate (DEHP) and other phthlates in the general population. Int J Hyg Environ Health. 2003;206:77-83.
35. Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ, et al. Levels of seven urinary phthalate metabolites in a human reference population. Environ Health Perspect. 2000;108:979-982.
36. Latini G, De Felice C, Presta G, Del Vecchio A, Paris I, Ruggieri F, Mazzeo P. In utero exposure to di-(2- ethylhexyl)phthalate and duration of human pregnancy. Environ Health Perspect. 2003;111:1783-1785.
37. Silva MJ, Barr DB, Reidy JA, Malek NA, Hodge CC, Caudill SP, et al. Urinary levels of seven phthalate metabolites in the U.S. population from the National Health and Nutrition Examination Survey (NHANES) 1999-2000. Environ Health Perspect. 2004;112:331-338.
38. Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, Mao CS, Redmon JB, Ternand CL, Sullivan S et al. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect. 2005; 113:1056-1061.
39. Main KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, Chellakooty M, Schmidt IM, Suomi AM, Virtanen HE, Petersen DV, Andersson AM, Toppari J, Skakkebaek NE. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect. 2006;11:270-276.
40. Högberg J, Hanberg A, Berglund M, Skerfving S, Remberger M, Calafat AM, Filipsson AF, Jansson B, Johansson N, Appelgren M, Hakansson H. Phthalate diesters and their metabolites in human breast milk, blood or serum, and urine as biomarkers of exposure in vulnerable populations. Environ Health Perspect. 2008;116:334-339.
41. Huang PC, Kuo PL, Chou YY, Lin SJ, Lee CC. Association between prenatal exposure to phthalates and the health of newborns. Environ Int. 2009;35:14-20.
42. Shaffer CB, Carpenter CP, Smyth HR Jr. Acute and subacute toxicity of di-(2-ethylhexyl)phthalate with note upon its metabolism. J Ind Hyg Toxicol. 1945;27:130-135.
43. Harris RS, Hodge HC, Maynard ER and Blancher HJ Jr. Chronic oral toxicity of 2-ethylhexyl phthalate in rats and dogs. Arch Ind Hyg. 1956;13:259-264.
44. Gangolli SD. Testicular effects of phthalate esters. Environ Health Perspect. 1982;45:77-84.
45. Foster PM. Disruption of reproductive development in male rat offspring following in utero exposure to phthalate esters. Int J Androl. 2006;29:140-147; discussion 181-1145
46. Mylchreest E, Wallace DG, Cattley RC, Foster PM. Dosedependent alterations in androgen-regulated male reproductive development in rats exposed to Di(n-butyl) phthalate during late gestation. Toxicol Sci. 2000;55:143-151.
47. Parks LG, Ostby JS, Lambright CR, Abbott BD, Klinefelter GR, Barlow NJ, et al. The plasticizer diethylhexyl phthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci. 2000;58:339-349.
48. Lehmann KP, Phillips S, Sar M, Foster PM, Gaido K. Dosedependent alterations in gene expression and testosterone synthesis in the fetal testes of male rats exposed to di (n-butyl) phthalate. Toxicol Sci. 2004;81:60-68.
49. Wilson VS, Lambright C, Furr J, Ostby J, Wood C, Held G, Gray LE, Jr. Phthalate ester-induced gubernacular lesions are associated with reduced insl3 gene expression in the fetal rat testis. Toxicol Lett. 2004;146:207-215.
50. Mahood IK, Hallmark N, McKinnell C, Walker M, Fisher JS, Sharpe RM. Abnormal Leydig cell aggregation in the fetal testis of rats exposed to di (n-butyl) phthalate and its possible role in testicular dysgenesis. Endocrinology. 2005;146:613-623.
51. McKinnell C, Sharpe RM, Mahood K, Hallmark N, Scott H, Ivell R, Staub C, Jegou B, Haag F, Koch-Nolte F, Hartung S. Expression of insulin-like factor 3 protein in the rat testis during fetal and postnatal development and in relation to cryptorchidism induced by in utero exposure to di (n-Butyl) phthalate. Endocrinology. 2005;146:4536-4544.
52. Howdeshell KL, Wilson VS, Furr J, Lambright CR, Rider CV, Blystone CR, Hotchkiss AK, Gray LE Jr. A mixture of five phthalate esters inhibits fetal testicular testosterone production in the sprague-dawley rat in a cumulative, dose-additive manner. Toxicol Sci. 2008;105:153-165.
53. Scott HM, Hutchison GR, Mahood IK, Hallmark N, Welsh M, de Gendt K, et al. Role of androgens in fetal testis development and dysgenesis. Endocrinology 2007;148:2027-2036.
54. Fisher JS, Macpherson S, Marchetti N, Sharpe RM. Human "testicular dysgenesis syndrome": a possible model using inutero exposure of the rat to dibutyl phthalate. Hum Reprod. 2003;18:1383-1394
55. Fisher JS. Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome. Reproduction. 2004;127:305-315.
56. Ferrara D, Hallmark N, Scott H, Brown R, McKinnell C, Mahood IK, Sharpe RM. Acute and long-term effects of in utero exposure of rats to di(n-butyl) phthalate on testicular germ cell development and proliferation. Endocrinology. 2006;147:5352-5362.
57. Gautier C, Levacher C, Saez JM, Habert R. Transforming Growth Factor ?1 inhibits steroidogenesis in dispersed fetal testicular cells in culture. Mol Cell Endocrinol. 1997;131:21-30.
58. Rouiller-Fabre L, Carmona S, Abou-Merhi R, Cate R, Habert R, Vigier B. Effect of anti-Müllerian hormone (AMH) on Sertoli and Leydig cell functions in fetal and immature rats. Endocrinology. 1998;139:1213-1220.
59. Rouiller-Fabre V, Lecerf L, Gautier C, Saez JM, Habert R. Expression and effect of Insulin-like Growth Factor I on rat fetal Leydig cell function and differentiation. Endocrinology. 1998;139:2926-2934.
60. Van Dissel-Emiliani FM, de Boer-Brouwer M, Spek ER, van der Donk JA, de Rooij DJ. Survival and proliferation of rat gonocytes in vitro. Cell Tissue Res. 1993;273:141-147.
61. Li H, Papadapoulos V, Vidic B, Dym M, Culty M. Regulation of rat testis gonocyte proliferation by platelet-derived growth factor and estradiol: identification of signaling mechanisms involved. Endocrinology. 1997;138:1289-1298.
62. Boulogne B, Habert R, Levacher C. Regulation of the proliferation of cocultured gonocytes and Sertoli cells by retinoids, triiodothyronine, and intracellular signaling factors: differences between fetal and neonatal cells. Mol Reprod Dev. 2003;65:194-203.
63. Habert R, Devif I, Gangnerau MN, Lecerf L. Ontogenesis of the in vitro response of rat testis to gonadotropin-releasing hormone. Mol Cell Endocrinol. 1991;82:199-206.
64. Lecerf L, Rouiller-Fabre V, Levacher C, Gautier C, Saez J, Habert R. Stimulatory effect of follicle-stimulating hormone on basal and luteinizing hormone-stimulated testosterone secretion by fetal rat testis in vitro. Endocrinology. 1993; 133:2313-2318.
65. Olaso R, Pairault C, Boulogne B, Durand P, Habert R. Transforming Growth Factor β1 and β2 reduce the number of gonocytes by increasing apoptosis. Endocrinology. 1998;139:733-740.
66. Livera G, Rouiller-Fabre V, Durand P, Habert R. Multiple effects of retinoids on the development of Sertoli, germ and Leydig cells of fetal and neonatal rat testis in culture. Biol Reprod. 2000;62:1303-2131
67. Livera G, Delbes G, Pairault C, Rouiller-Fabre V, Habert R. Organotypic culture, a powerful model for studying rat and mouse fetal testis development. Cell Tissue Res. 2006;324:507-521.
68. Lambrot R, Coffigny H, Pairault C, Frydman R, Habert R, Rouiller-Fabre V. Use of organ culture to study the human fetal testis development: effect of retinoic acid. J Clin Endoc Metab. 2006;91:2696-2703.
69. Lambrot R, Coffigny H, Pairault C, Frydman R, Habert R & Rouiller-Fabre V. High radiosensitivity of germ cells in human male fetus. J Clin Endoc Metab. 2007;92:2632-2639.
70. Lambrot R, Livera G, Coffigny H, Pairault C, Frydman R, Habert R, Rouiller-Fabre V. Anew method for toxicity assays on human and mouse fetal testis. Biochimie. 2006;88:1831-1835.
71. Hallmark N, Walker M, McKinnell C, Mahood IK, Scott H, Bayne R, Coutts S, Anderson RA, Greig I, Morris K, Sharpe RM. Effects of monobutyl and di(n-butyl) phthalate in vitro on steroidogenesis and Leydig cell aggregation in fetal testis explants from the rat: comparison with effects in vivo in the fetal rat and neonatal marmoset and in vitro in the human. Environ Health Perspect. 2007;115:390-396.
72. Li H, Kim KH. Effects of mono-(2-ethylhexyl) phthalate on fetal and neonatal rat testis organ cultures. Biol Reprod. 2003; 69:1964-1972. (Pubitemid 37505343)
73. Stroheker T, Regnier JF, Lassurguere J, Chagnon MC. Effect of in utero exposure to di-(2-ethylhexyl)phthalate: distribution in the rat fetus and testosterone production by rat fetal testis in culture. Food Chem Toxicol. 2006;44:2064-2069
74. Chauvigné F, Menuet A, Lesné L, Chagnon MC, Chevrier C, Regnier JF, Angerer J, Jégou B. Time- and Dose-Related Effects of Di-(2-ethylhexyl) Phthalate and its Main Metabolites on the Function of the Rat Fetal Testis in vitro. Environ Health Perspect. in press.
75. Storgaard L, Bonde JP, Olsen J. Male reproductive disorders in humans and prenatal indicators of estrogen exposure. A review of published epidemiological studies. Cell Tissue Res. 2006;21: 4-15.
76. Lambrot R, Muczynski V, Lécureuil C, Angenard G, Coffigny H, Pairault C, Moison D, Frydman R, Habert R, Rouiller- Fabre V. Phthalates impair germ cell development in the human fetal testis in vitro without change in testosterone production. Environ Health Perspect. 2009;117:32-37.
77. Welsh M, Saunders PT, Fisken M, Scott HM, Hutchison GR, Smith LB, et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J Clin Invest. 2008;118:1479-1490.
78. Gaido KW, Hensley JB, Liu D, Wallace DG, Borghoff S, Johnson KJ, Hall SJ, Boekelheide K. Fetal mouse phthalate exposure shows that Gonocyte multinucleation is not associated with decreased testicular testosterone. Toxicol Sci. 2007; 97:491-503.
79. Lehraiki A, Szenker J, Habert R, Levacher C. In vivo and in vitro adverse effects of phthalates on fetal and neonatal mouse gonocytes 15th European Testis Workshop. Naantali- Finland Miniposter N° 43. 2008. Available in http://etw15.utu.fi/?id= miniposters&pm=main|miniposters